The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge-Implications for Health Services Implementation
- PMID: 36929823
- DOI: 10.1093/cid/ciad156
The Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge-Implications for Health Services Implementation
Abstract
Inpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective, multicenter cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.
Keywords: amoxicillin allergy; antimicrobial stewardship; beta-lactam allergy; drug allergy; oral provocation.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. A. P. D. reports lecture honoraria from Gilead Sciences, paid directly to institution and unrelated to this work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment in
-
Implementing Delabeling of Beta-Lactam Allergies: Getting to the "Why"?Clin Infect Dis. 2023 Jul 5;77(1):23-24. doi: 10.1093/cid/ciad152. Clin Infect Dis. 2023. PMID: 36928936 No abstract available.
-
Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling.Clin Infect Dis. 2024 Jan 25;78(1):227. doi: 10.1093/cid/ciad478. Clin Infect Dis. 2024. PMID: 37585654 No abstract available.